Search
for

    Sort by

    Research 571–600 of 1000+

    1. 5α‐Reductase Inhibitors Andrology · 1997 · 17 citations
    2. The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy Biomedicines · 2020 · 11 citations
    3. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases Current Medicinal Chemistry · 2016 · 11 citations
    4. Proscar and Propecia—A Therapeutic Perspective The Journal of Clinical Endocrinology & Metabolism · 2004 · 8 citations
    5. Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia BMC Urology · 2022 · 6 citations
    6. How to Read a Research Paper 2018 · 5 citations
    7. Pathogenetic justification of the use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Experimental and Сlinical Urology · 2022 · 4 citations
    8. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    9. Potential roles of FGF5 as a candidate therapeutic target in prostate cancer. PubMed · 2023 · 2 citations
    10. Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq Baghdad Science Journal · 2020 · 2 citations
    11. Finasteride Springer eBooks · 2011 · 2 citations
    12. Effect of metabolic syndrome on treatment outcome of lower urinary tract symptoms in males due to benign prostatic hyperplasia Panacea Journal of Medical Sciences · 2020 · 1 citations
    13. Lower Urinary Tract Symptoms in Men JAMA · 2025
    14. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    15. Saw Palmetto (Serenoa repens) Elsevier eBooks · 2021
    16. Saw Palmetto (Serenoa repens) Elsevier eBooks · 2018
    17. 5α‐Reductase Inhibitors 2014
    18. 5ARI and PSA: open questions Urologia Journal · 2014
    19. Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование Курский научно-практический вестник "Человек и его здоровье" · 2012
    20. New Drugs: Dutasteride Australian Prescriber · 2009
    21. Finasteride 2008
    22. Eficacia de la combinación de doxazosina y finasterida en la hipertrofia benigna de próstata Actualidad en farmacología y terapéutica · 2004
    23. Control of testosterone 5alpha-reductase activity in the human hyperplastic prostate Enlighten: Theses (The University of Glasgow) · 1978
    24. A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits Journal of Drug Delivery and Therapeutics · 2019
    25. Post-Finasteride Syndrome: An Underestimated Phenomenon Urology and andrology · 2017
    26. Phytochemical, Chemotaxonomic and Bioinformatics Study on <i>Laportea bulbifera</i> (Urticaceae) Chemistry & biodiversity · 2022 · 6 citations
    27. Sex Hormones: Hormonal Contraception and Hormone Replacement Therapy 2019 · 2 citations
    28. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia Clinical Breast Cancer · 2019 · 1 citations
    29. Serenoa repens: A Phytochemical and Pharmacological Review Egyptian Journal of Chemistry · 2024
    30. Medicine Update IJCP · 2024